Entropy Technologies LP lessened its holdings in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 5.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 51,244 shares of the company’s stock after selling 3,069 shares during the quarter. Entropy Technologies LP’s holdings in Colgate-Palmolive were worth $4,659,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. D Orazio & Associates Inc. grew its holdings in Colgate-Palmolive by 3.9% during the 3rd quarter. D Orazio & Associates Inc. now owns 2,862 shares of the company’s stock valued at $297,000 after buying an additional 108 shares in the last quarter. Fiducient Advisors LLC boosted its holdings in shares of Colgate-Palmolive by 5.2% in the 3rd quarter. Fiducient Advisors LLC now owns 2,231 shares of the company’s stock worth $232,000 after purchasing an additional 110 shares during the period. Sequoia Financial Advisors LLC boosted its holdings in shares of Colgate-Palmolive by 0.6% in the 3rd quarter. Sequoia Financial Advisors LLC now owns 20,392 shares of the company’s stock worth $2,117,000 after purchasing an additional 113 shares during the period. Waldron Private Wealth LLC boosted its holdings in shares of Colgate-Palmolive by 2.1% in the 3rd quarter. Waldron Private Wealth LLC now owns 5,632 shares of the company’s stock worth $585,000 after purchasing an additional 118 shares during the period. Finally, Commonwealth Financial Services LLC lifted its stake in shares of Colgate-Palmolive by 4.5% during the 4th quarter. Commonwealth Financial Services LLC now owns 2,716 shares of the company’s stock worth $247,000 after acquiring an additional 118 shares during the last quarter. Institutional investors own 80.41% of the company’s stock.
Analyst Upgrades and Downgrades
A number of equities research analysts recently issued reports on the company. TD Cowen decreased their price target on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research note on Wednesday, January 8th. StockNews.com lowered Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. Royal Bank of Canada reissued a “sector perform” rating and issued a $101.00 price target on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. UBS Group reduced their price target on Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating for the company in a research report on Monday, February 3rd. Finally, Barclays reduced their price target on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a research report on Friday, January 17th. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have given a buy rating to the stock. According to MarketBeat, Colgate-Palmolive presently has a consensus rating of “Hold” and a consensus target price of $101.16.
Colgate-Palmolive Stock Up 1.3 %
Colgate-Palmolive stock opened at $86.81 on Friday. The firm has a market cap of $70.93 billion, a price-to-earnings ratio of 24.66, a price-to-earnings-growth ratio of 4.12 and a beta of 0.44. Colgate-Palmolive has a 52 week low of $82.68 and a 52 week high of $109.30. The business’s 50-day moving average price is $90.36 and its 200 day moving average price is $96.76. The company has a quick ratio of 0.26, a current ratio of 0.41 and a debt-to-equity ratio of 9.46.
Colgate-Palmolive (NYSE:CL – Get Free Report) last released its earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period in the prior year, the firm earned $0.87 EPS. As a group, sell-side analysts anticipate that Colgate-Palmolive will post 3.73 earnings per share for the current year.
Colgate-Palmolive Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be given a dividend of $0.50 per share. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a yield of 2.30%. Colgate-Palmolive’s payout ratio is 56.82%.
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Stories
- Five stocks we like better than Colgate-Palmolive
- What Are Some of the Best Large-Cap Stocks to Buy?
- Chipotle’s Slip: A Short-Term Dip or Long-Term Opportunity?
- What is a Special Dividend?
- Why New Tariffs Could Boost These 3 Basic Materials Stocks
- High Flyers: 3 Natural Gas Stocks for March 2022
- MarketBeat Week in Review – 02/03 – 02/07
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.